Workflow
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

Editas Medicine (EDIT) came out with a quarterly loss of 0.43pershareversustheZacksConsensusEstimateofalossof0.43 per share versus the Zacks Consensus Estimate of a loss of 0.51. This compares to loss of 0.76pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof15.690.76 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.69%. A quarter ago, it was expected that this genome editing company would post a loss of 0.39 per share when it actually produced a loss of $0.55, delivering a surprise of -41.03%.Over the last four quarters, the comp ...